Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

63°
- Benton, AR (72018)
  Today
  
  Sun and clouds mixed. High 67F. Winds ENE at 10 to 20 mph..
  
  Tonight
  
  Partly cloudy early followed by cloudy skies overnight. Low 49F. Winds ENE at 5 to 10 mph.
  
  Updated: March 23, 2026 @ 12:00 pm
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2026
Community Calendar

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Centessa Pharmaceuticals plc - American Depositary Shares (NQ:CNTA)

25.99 -1.07 (-3.95%)

Streaming Delayed Price Updated: 1:04 PM EDT, Mar 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Centessa Pharmaceuticals plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2023 ↗

June 21, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023 ↗

June 12, 2023

Via Benzinga

Centessa Pharmaceuticals: Q1 Earnings Insights ↗

May 12, 2023

Via Benzinga

NASDAQ: CNTA Investor Alert: Deadline on November 28, 2022 in Lawsuit against Centessa Pharmaceuticals plc ↗

November 28, 2022

San Diego, CA -- (SBWIRE) -- 11/28/2022 --

Via SBWire

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

May 24, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Receives Fast Track Designation from the U.S. FDA for SerpinPC for Hemophilia B

May 22, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2023

May 12, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Reports Recent Business Progress and Financial Results for the Fourth Quarter and Full-Year 2022

March 30, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

March 27, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces Addition of Patrick Yue, MD, as Senior Vice President of Clinical Development, Innovative Medicines

March 01, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023 ↗

March 17, 2023

Via Benzinga

Centessa Pharmaceuticals Plc (NASDAQ:CNTA) Long Term Shareholder Notice: Investigation of Potential Wrongdoing ↗

February 14, 2023

San Diego, CA -- (SBWIRE) -- 02/14/2023 -- An investigation was announced for investors in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA) concerning potential breaches of fiduciary duties by...

Via SBWire

Centessa Pharmaceuticals to Present Additional Data from Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for Hemophilia at the 16th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)

February 06, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces Presentation at the SVB Securities Global Biopharma Conference

February 02, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of LB101, First LockBody® Candidate, for Solid Tumors

January 26, 2023

LB101 is a conditionally tetravalent PD-L1xCD47 LockBody bispecific monoclonal antibody being developed for solid tumors

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces Additional 18-Months of Continued Treatment Data from Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for Hemophilia

December 10, 2022

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces New Chief People Officer Karen Anderson

November 30, 2022

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Bronstein, Gewirtz & Grossman, LLC, A Top Firm, Reminds Centessa Pharmaceuticals plc (CNTA) Investors of Class Action Deadline and Encourages Investors to Actively Participate

November 28, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Olo, Centessa, PayPal, and Opendoor and Encourages Investors to Contact the Firm

November 27, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

CENTESSA PHARMACEUTICALS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Deadline in Class Action Lawsuit Against Centessa Pharmaceuticals plc - CNTA

November 25, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

CENTESSA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Centessa Pharmaceuticals Plc and Encourages Investors to Contact the Firm

November 25, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Best Buy, Abercrombie & Fitch, Burlington Stores And Some Other Big Stocks Moving Higher On Tuesday ↗

November 22, 2022

U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Olo, Centessa, PayPal, and Opendoor and Encourages Investors to Contact the Firm

November 21, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Olo, Centessa, PayPal, and Opendoor and Encourages Investors to Contact the Firm

November 16, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Warner Bros., Olo, Centessa, and PayPal and Encourages Investors to Contact the Firm

November 11, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2022

November 10, 2022

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Olo, Centessa, PayPal, and Opendoor and Encourages Investors to Contact the Firm

November 06, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Centessa Pharmaceuticals to Present Additional 18-Months of Continued Treatment Data with SerpinPC from Open-Label Extension of Phase 2a Study at 64th ASH Annual Meeting

November 03, 2022

New efficacy and safety data from 18-months of continued treatment with subcutaneous doses of SerpinPC in subjects with hemophilia accepted for oral presentation

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Warner Bros., Olo, Centessa, and PayPal and Encourages Investors to Contact the Firm

October 31, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

October 31, 2022

From Centessa Pharmaceuticals plc

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

Centessa Pharmaceuticals plc - American Depositary Shares (NQ:CNTA)

All News about Centessa Pharmaceuticals plc - American Depositary Shares

Sections

Services

Follow Us